Author： Adis International Limited
Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.5, Iss.6, 2004-01, pp. : 339-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Henness Sheridan Keating Gillian M.
Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. :
Access to resources
Recommend
Natalizumab in MS well tolerated
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Alemtuzumab effective in MS, but at a cost
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :